Insmed Inc. buy Royal Bank of Canada
Start price
11.06.25
/
50%
€86.50
Target price
11.06.26
€92.91
Performance (%)
-3.46%
End price
12.06.26
€83.51
Summary
This prediction ended on 12.06.26 with a price of €83.51. With a performance of -3.46%, the BUY prediction for Insmed Inc. by Royal_Bank_of_Canada closed slightly in the red. Royal_Bank_of_Canada has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.078% | -3.078% | 3.898% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Royal Bank of Canada from $99.00 to $106.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten